Authors: Joulia, JM Pinguet, F Ychou, M Duffour, J Astre, C Bressolle, F

Citation: Jm. Joulia et al., Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid, EUR J CANC, 35(2), 1999, pp. 296-301

Authors: Grosse, PY Bressolle, F Rouanet, P Joulia, JM Pinguet, F

Citation: Py. Grosse et al., Methyl-beta-cyclodextrin and doxorubicin pharmacokinetics and tissue concentrations following bolus injection of these drugs alone or together in therabbit, INT J PHARM, 180(2), 1999, pp. 215-223

Authors: Bressolle, F Joulia, JM Pinguet, F Ychou, M Astre, C Duffour, J Gomeni, R

Citation: F. Bressolle et al., Circadian rhythm of 5-fluorouracil population pharmacokinetics in patientswith metastatic colorectal cancer, CANC CHEMOT, 44(4), 1999, pp. 295-302

Authors: Ychou, M Duffour, J Pinguet, F Kramar, A Joulia, JM Topart, D Bressolle, F

Citation: M. Ychou et al., Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: A feasibility study in patients with advanced colorectal cancer, ANTICANC R, 19(3B), 1999, pp. 2229-2235